Jeannie Callum is a transfusion medicine specialist and hematologist in Ontario, Canada.[1] She is also a professor at the University of Toronto and Queen's University.[2] She was the co-principal investigator of the CONCOR[3] trial, an international randomized controlled trial evaluating the use of convalescent plasma for the treatment of COVID-19 infection.[2][4] She was lead editor for Bloody Easy 4: Blood Transfusions, Blood Alternatives and Transfusion Reactions, fourth edition a handbook in transfusion medicine for the province of Ontario.[5]

A photograph of Dr. Jeannie Callum with hands clasped, facing the camera
Jeannie Callum

Further reading

edit
  • "Bloody Easy 4: Blood Transfusions, Blood Alternatives and Transfusion Reactions. A Guide to Transfusion Medicine, fourth Edition Handbook". Ontario Regional Blood Coordinating Network. Retrieved 2021-11-09.
  • "Bloody Easy 4: Blood Transfusions, Blood Alternatives and Transfusion Reactions" (PDF). 2016. Retrieved November 9, 2021.

References

edit
  1. ^ "Using plasma to treat COVID-19 still in question after clinical trial results". CBC. Retrieved November 9, 2021.
  2. ^ a b "Major study finds convalescent plasma doesn't help seriously ill COVID-19 patients". Newswise. September 9, 2021. Retrieved November 9, 2021.
  3. ^ Bégin, Philippe; Callum, Jeannie; Jamula, Erin; Cook, Richard; Heddle, Nancy M.; Tinmouth, Alan; Zeller, Michelle P.; Beaudoin-Bussières, Guillaume; Amorim, Luiz; Bazin, Renée; Loftsgard, Kent Cadogan (2021-09-09). "Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial". Nature Medicine. 27 (11): 2012–2024. doi:10.1038/s41591-021-01488-2. ISSN 1546-170X. PMC 8604729. PMID 34504336. S2CID 237469785.
  4. ^ "Large Study Finds Convalescent Plasma Doesn't Help Seriously Ill COVID-19 Patients". WCM Newsroom. Retrieved 2021-11-09.
  5. ^ Bain, B. J. (2005-06-01). "Bloody Easy: Blood Transfusions, Blood Alternatives and Transfusion Reactions: a Guide to Transfusion Medicine". Journal of Clinical Pathology. 58 (6): 672. ISSN 0021-9746.